Join
Live feed
·
PRReleasevia Quantisnow
Sorrento Therapeutics Inc. logo

Sorrento Announces That It Has Acquired a Majority Ownership in Diagnostic Manufacturer Zhengzhou Fortune Bioscience in Response to Increasing Worldwide Demand For COVISTIX™

ByQuantisnow·Wall Street's wire, on your screen.
SRNE· Sorrento Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SRNE (Sorrento Therapeutics Inc.) and more on Quantisnow.